| 2.4 |
7.2 |
GO:0035408 |
histone H3-T6 phosphorylation(GO:0035408) |
| 1.6 |
4.7 |
GO:0010586 |
miRNA metabolic process(GO:0010586) miRNA catabolic process(GO:0010587) |
| 1.2 |
7.3 |
GO:0007256 |
activation of JNKK activity(GO:0007256) |
| 0.8 |
2.3 |
GO:0046015 |
carbon catabolite regulation of transcription(GO:0045990) regulation of transcription by glucose(GO:0046015) positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus(GO:1901522) |
| 0.5 |
1.4 |
GO:0060120 |
auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
| 0.5 |
1.4 |
GO:0034139 |
regulation of toll-like receptor 3 signaling pathway(GO:0034139) |
| 0.4 |
1.3 |
GO:0070816 |
phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
| 0.4 |
2.9 |
GO:0051571 |
positive regulation of histone H3-K4 methylation(GO:0051571) |
| 0.4 |
2.2 |
GO:0009649 |
entrainment of circadian clock(GO:0009649) |
| 0.4 |
2.6 |
GO:0040032 |
post-embryonic body morphogenesis(GO:0040032) |
| 0.3 |
2.8 |
GO:0000185 |
activation of MAPKKK activity(GO:0000185) |
| 0.3 |
2.8 |
GO:0045647 |
negative regulation of erythrocyte differentiation(GO:0045647) |
| 0.3 |
0.9 |
GO:0070734 |
histone H3-K27 methylation(GO:0070734) |
| 0.3 |
1.2 |
GO:0021759 |
globus pallidus development(GO:0021759) menarche(GO:0042696) |
| 0.3 |
0.6 |
GO:0060574 |
intestinal epithelial cell maturation(GO:0060574) intestinal epithelial cell development(GO:0060576) |
| 0.3 |
0.8 |
GO:0019056 |
modulation by virus of host transcription(GO:0019056) regulation of sprouting of injured axon(GO:0048686) positive regulation of sprouting of injured axon(GO:0048687) regulation of axon extension involved in regeneration(GO:0048690) positive regulation of axon extension involved in regeneration(GO:0048691) modulation by symbiont of host transcription(GO:0052026) |
| 0.3 |
2.2 |
GO:0007064 |
mitotic sister chromatid cohesion(GO:0007064) |
| 0.3 |
1.4 |
GO:0001672 |
regulation of chromatin assembly or disassembly(GO:0001672) |
| 0.3 |
1.6 |
GO:0045943 |
positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
| 0.3 |
0.8 |
GO:0007109 |
obsolete cytokinesis, completion of separation(GO:0007109) protein hexamerization(GO:0034214) |
| 0.3 |
1.3 |
GO:0045767 |
obsolete regulation of anti-apoptosis(GO:0045767) |
| 0.3 |
1.5 |
GO:0021877 |
forebrain neuron fate commitment(GO:0021877) |
| 0.2 |
0.5 |
GO:0061140 |
lung secretory cell differentiation(GO:0061140) |
| 0.2 |
1.7 |
GO:0060033 |
anatomical structure regression(GO:0060033) |
| 0.2 |
0.7 |
GO:0001779 |
natural killer cell differentiation(GO:0001779) |
| 0.2 |
1.6 |
GO:0043457 |
regulation of cellular respiration(GO:0043457) |
| 0.2 |
1.7 |
GO:0043982 |
histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
| 0.2 |
0.9 |
GO:0033602 |
negative regulation of gamma-aminobutyric acid secretion(GO:0014053) negative regulation of dopamine secretion(GO:0033602) |
| 0.2 |
1.8 |
GO:0043923 |
positive regulation by host of viral transcription(GO:0043923) |
| 0.2 |
1.4 |
GO:0033160 |
positive regulation of protein import into nucleus, translocation(GO:0033160) |
| 0.2 |
0.6 |
GO:0018076 |
N-terminal peptidyl-lysine acetylation(GO:0018076) |
| 0.2 |
0.6 |
GO:0021919 |
BMP signaling pathway involved in spinal cord dorsal/ventral patterning(GO:0021919) |
| 0.2 |
1.3 |
GO:0090005 |
negative regulation of establishment of protein localization to plasma membrane(GO:0090005) negative regulation of protein localization to plasma membrane(GO:1903077) negative regulation of protein localization to cell periphery(GO:1904376) |
| 0.2 |
0.7 |
GO:0048935 |
peripheral nervous system neuron development(GO:0048935) |
| 0.2 |
0.9 |
GO:0017055 |
negative regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0017055) |
| 0.2 |
1.6 |
GO:0048387 |
negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
| 0.2 |
7.1 |
GO:0006270 |
DNA replication initiation(GO:0006270) |
| 0.2 |
1.7 |
GO:0001866 |
NK T cell proliferation(GO:0001866) |
| 0.2 |
0.5 |
GO:0042501 |
serine phosphorylation of STAT protein(GO:0042501) |
| 0.2 |
0.7 |
GO:2000114 |
regulation of establishment of cell polarity(GO:2000114) |
| 0.2 |
1.7 |
GO:0048096 |
chromatin-mediated maintenance of transcription(GO:0048096) |
| 0.2 |
0.5 |
GO:0060316 |
positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
| 0.1 |
1.4 |
GO:0007379 |
segment specification(GO:0007379) |
| 0.1 |
0.7 |
GO:0001302 |
replicative cell aging(GO:0001302) female genitalia morphogenesis(GO:0048807) |
| 0.1 |
0.3 |
GO:0007418 |
ventral midline development(GO:0007418) |
| 0.1 |
0.5 |
GO:0031936 |
negative regulation of chromatin silencing(GO:0031936) |
| 0.1 |
0.3 |
GO:0051365 |
cellular response to potassium ion starvation(GO:0051365) |
| 0.1 |
1.0 |
GO:0051294 |
establishment of mitotic spindle orientation(GO:0000132) establishment of spindle orientation(GO:0051294) |
| 0.1 |
0.3 |
GO:0021797 |
forebrain anterior/posterior pattern specification(GO:0021797) |
| 0.1 |
1.2 |
GO:0016180 |
snRNA processing(GO:0016180) |
| 0.1 |
1.4 |
GO:0032876 |
regulation of DNA endoreduplication(GO:0032875) negative regulation of DNA endoreduplication(GO:0032876) DNA endoreduplication(GO:0042023) |
| 0.1 |
0.7 |
GO:0048172 |
regulation of short-term neuronal synaptic plasticity(GO:0048172) |
| 0.1 |
0.7 |
GO:0007352 |
zygotic specification of dorsal/ventral axis(GO:0007352) |
| 0.1 |
0.8 |
GO:0060766 |
negative regulation of androgen receptor signaling pathway(GO:0060766) |
| 0.1 |
0.3 |
GO:0007095 |
mitotic G2 DNA damage checkpoint(GO:0007095) negative regulation of smooth muscle cell differentiation(GO:0051151) |
| 0.1 |
0.5 |
GO:0032959 |
inositol trisphosphate biosynthetic process(GO:0032959) positive regulation of penile erection(GO:0060406) |
| 0.1 |
0.7 |
GO:0016584 |
nucleosome positioning(GO:0016584) |
| 0.1 |
0.5 |
GO:0043619 |
regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0043619) |
| 0.1 |
0.5 |
GO:0060684 |
epithelial-mesenchymal cell signaling(GO:0060684) |
| 0.1 |
1.6 |
GO:0071451 |
removal of superoxide radicals(GO:0019430) cellular response to oxygen radical(GO:0071450) cellular response to superoxide(GO:0071451) cellular oxidant detoxification(GO:0098869) cellular detoxification(GO:1990748) |
| 0.1 |
0.8 |
GO:0006646 |
phosphatidylethanolamine biosynthetic process(GO:0006646) phosphatidylethanolamine metabolic process(GO:0046337) |
| 0.1 |
0.5 |
GO:0043984 |
histone H4-K16 acetylation(GO:0043984) |
| 0.1 |
0.7 |
GO:0015705 |
iodide transport(GO:0015705) |
| 0.1 |
0.4 |
GO:0045945 |
positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
| 0.1 |
0.5 |
GO:0051965 |
positive regulation of synapse assembly(GO:0051965) |
| 0.1 |
0.3 |
GO:0032223 |
negative regulation of synaptic transmission, cholinergic(GO:0032223) neurotransmitter receptor biosynthetic process(GO:0045212) |
| 0.1 |
0.7 |
GO:0002052 |
positive regulation of neuroblast proliferation(GO:0002052) |
| 0.1 |
0.4 |
GO:0033211 |
adiponectin-activated signaling pathway(GO:0033211) |
| 0.1 |
0.3 |
GO:0043490 |
malate-aspartate shuttle(GO:0043490) |
| 0.1 |
0.4 |
GO:0010832 |
negative regulation of myotube differentiation(GO:0010832) |
| 0.1 |
0.2 |
GO:0032714 |
negative regulation of interleukin-5 production(GO:0032714) |
| 0.1 |
1.2 |
GO:0060736 |
prostate gland growth(GO:0060736) |
| 0.1 |
1.0 |
GO:0002076 |
osteoblast development(GO:0002076) |
| 0.1 |
1.3 |
GO:0000380 |
alternative mRNA splicing, via spliceosome(GO:0000380) |
| 0.1 |
0.1 |
GO:0006344 |
maintenance of chromatin silencing(GO:0006344) |
| 0.1 |
0.4 |
GO:0051481 |
negative regulation of cytosolic calcium ion concentration(GO:0051481) cellular response to zinc ion(GO:0071294) |
| 0.1 |
0.4 |
GO:0015742 |
alpha-ketoglutarate transport(GO:0015742) |
| 0.1 |
0.1 |
GO:0071635 |
negative regulation of transforming growth factor beta production(GO:0071635) |
| 0.1 |
0.6 |
GO:0002553 |
histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) |
| 0.1 |
0.6 |
GO:0043545 |
Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
| 0.1 |
0.3 |
GO:0048295 |
positive regulation of isotype switching to IgE isotypes(GO:0048295) |
| 0.1 |
0.3 |
GO:0032933 |
response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
| 0.1 |
0.3 |
GO:0045048 |
protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
| 0.1 |
0.3 |
GO:0045299 |
otolith mineralization(GO:0045299) |
| 0.1 |
0.3 |
GO:0060999 |
positive regulation of dendritic spine development(GO:0060999) positive regulation of dendritic spine morphogenesis(GO:0061003) |
| 0.1 |
0.8 |
GO:0030889 |
negative regulation of B cell proliferation(GO:0030889) |
| 0.1 |
0.6 |
GO:0009404 |
toxin metabolic process(GO:0009404) |
| 0.1 |
0.5 |
GO:0006072 |
glycerol-3-phosphate metabolic process(GO:0006072) |
| 0.1 |
0.6 |
GO:0045084 |
positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
| 0.1 |
0.4 |
GO:0030828 |
positive regulation of cGMP biosynthetic process(GO:0030828) |
| 0.1 |
0.4 |
GO:0002092 |
positive regulation of receptor internalization(GO:0002092) |
| 0.1 |
0.8 |
GO:0090399 |
replicative senescence(GO:0090399) |
| 0.1 |
0.1 |
GO:0007538 |
primary sex determination(GO:0007538) |
| 0.1 |
0.6 |
GO:0016310 |
phosphorylation(GO:0016310) |
| 0.1 |
0.2 |
GO:0090281 |
negative regulation of calcium ion import(GO:0090281) |
| 0.1 |
0.5 |
GO:0015937 |
coenzyme A biosynthetic process(GO:0015937) |
| 0.1 |
0.4 |
GO:0005981 |
regulation of glycogen catabolic process(GO:0005981) |
| 0.1 |
0.3 |
GO:0045601 |
regulation of endothelial cell differentiation(GO:0045601) |
| 0.1 |
4.9 |
GO:0034339 |
obsolete regulation of transcription from RNA polymerase II promoter by nuclear hormone receptor(GO:0034339) |
| 0.1 |
0.2 |
GO:0001831 |
trophectodermal cellular morphogenesis(GO:0001831) |
| 0.1 |
0.5 |
GO:0035116 |
embryonic hindlimb morphogenesis(GO:0035116) |
| 0.1 |
0.7 |
GO:0051319 |
mitotic G2 phase(GO:0000085) G2 phase(GO:0051319) |
| 0.1 |
0.2 |
GO:0070634 |
transepithelial ammonium transport(GO:0070634) |
| 0.1 |
0.2 |
GO:0032927 |
positive regulation of activin receptor signaling pathway(GO:0032927) |
| 0.1 |
1.4 |
GO:1902583 |
multi-organism transport(GO:0044766) transport of virus(GO:0046794) intracellular transport of virus(GO:0075733) multi-organism localization(GO:1902579) multi-organism intracellular transport(GO:1902583) |
| 0.1 |
0.5 |
GO:1900087 |
traversing start control point of mitotic cell cycle(GO:0007089) positive regulation of G1/S transition of mitotic cell cycle(GO:1900087) positive regulation of cell cycle G1/S phase transition(GO:1902808) |
| 0.0 |
0.0 |
GO:0008300 |
isoprenoid catabolic process(GO:0008300) |
| 0.0 |
0.1 |
GO:0060664 |
epithelial cell proliferation involved in salivary gland morphogenesis(GO:0060664) |
| 0.0 |
1.7 |
GO:0006626 |
protein targeting to mitochondrion(GO:0006626) |
| 0.0 |
0.4 |
GO:0010452 |
histone H3-K36 methylation(GO:0010452) |
| 0.0 |
0.8 |
GO:1904031 |
positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) positive regulation of cyclin-dependent protein kinase activity(GO:1904031) |
| 0.0 |
1.0 |
GO:0006929 |
substrate-dependent cell migration(GO:0006929) |
| 0.0 |
0.5 |
GO:0006975 |
DNA damage induced protein phosphorylation(GO:0006975) |
| 0.0 |
0.3 |
GO:0045722 |
positive regulation of gluconeogenesis(GO:0045722) |
| 0.0 |
1.0 |
GO:0046854 |
phosphatidylinositol phosphorylation(GO:0046854) |
| 0.0 |
0.5 |
GO:0051103 |
DNA ligation involved in DNA repair(GO:0051103) |
| 0.0 |
0.2 |
GO:0032776 |
DNA methylation on cytosine(GO:0032776) C-5 methylation of cytosine(GO:0090116) |
| 0.0 |
0.6 |
GO:0001893 |
maternal placenta development(GO:0001893) |
| 0.0 |
0.3 |
GO:0060158 |
phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
| 0.0 |
0.6 |
GO:0001573 |
ganglioside metabolic process(GO:0001573) |
| 0.0 |
0.9 |
GO:0090630 |
activation of GTPase activity(GO:0090630) |
| 0.0 |
1.4 |
GO:0016571 |
histone methylation(GO:0016571) |
| 0.0 |
5.0 |
GO:0006333 |
chromatin assembly or disassembly(GO:0006333) |
| 0.0 |
1.3 |
GO:0006338 |
chromatin remodeling(GO:0006338) |
| 0.0 |
0.3 |
GO:0070934 |
CRD-mediated mRNA stabilization(GO:0070934) |
| 0.0 |
0.8 |
GO:0045670 |
regulation of osteoclast differentiation(GO:0045670) |
| 0.0 |
0.1 |
GO:0021571 |
rhombomere 4 development(GO:0021570) rhombomere 5 development(GO:0021571) facial nucleus development(GO:0021754) |
| 0.0 |
1.1 |
GO:0007214 |
gamma-aminobutyric acid signaling pathway(GO:0007214) |
| 0.0 |
0.1 |
GO:0031960 |
response to corticosteroid(GO:0031960) response to glucocorticoid(GO:0051384) |
| 0.0 |
1.0 |
GO:0018208 |
peptidyl-proline modification(GO:0018208) |
| 0.0 |
0.5 |
GO:0006376 |
mRNA splice site selection(GO:0006376) |
| 0.0 |
0.3 |
GO:0010765 |
positive regulation of sodium ion transport(GO:0010765) |
| 0.0 |
0.6 |
GO:0016578 |
histone deubiquitination(GO:0016578) |
| 0.0 |
0.5 |
GO:0006913 |
nucleocytoplasmic transport(GO:0006913) nuclear transport(GO:0051169) |
| 0.0 |
0.6 |
GO:0007520 |
myoblast fusion(GO:0007520) |
| 0.0 |
0.4 |
GO:0071044 |
histone mRNA catabolic process(GO:0071044) |
| 0.0 |
0.4 |
GO:0070389 |
chaperone cofactor-dependent protein refolding(GO:0070389) |
| 0.0 |
0.2 |
GO:0006177 |
GMP biosynthetic process(GO:0006177) |
| 0.0 |
0.3 |
GO:0046498 |
S-adenosylhomocysteine metabolic process(GO:0046498) |
| 0.0 |
0.1 |
GO:0033147 |
negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
| 0.0 |
0.1 |
GO:0021615 |
glossopharyngeal nerve development(GO:0021563) glossopharyngeal nerve morphogenesis(GO:0021615) |
| 0.0 |
0.1 |
GO:0042474 |
middle ear morphogenesis(GO:0042474) |
| 0.0 |
0.6 |
GO:0006890 |
retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
| 0.0 |
0.2 |
GO:0032464 |
positive regulation of protein homooligomerization(GO:0032464) |
| 0.0 |
0.2 |
GO:0006983 |
ER overload response(GO:0006983) |
| 0.0 |
0.4 |
GO:0009220 |
pyrimidine ribonucleotide biosynthetic process(GO:0009220) |
| 0.0 |
0.2 |
GO:0046831 |
regulation of RNA export from nucleus(GO:0046831) |
| 0.0 |
0.2 |
GO:0006572 |
tyrosine catabolic process(GO:0006572) |
| 0.0 |
0.7 |
GO:0003333 |
amino acid transmembrane transport(GO:0003333) |
| 0.0 |
0.2 |
GO:0042989 |
sequestering of actin monomers(GO:0042989) |
| 0.0 |
0.3 |
GO:0032784 |
regulation of DNA-templated transcription, elongation(GO:0032784) |
| 0.0 |
0.5 |
GO:0007398 |
ectoderm development(GO:0007398) |
| 0.0 |
0.7 |
GO:0000184 |
nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
| 0.0 |
0.2 |
GO:0001964 |
startle response(GO:0001964) |
| 0.0 |
0.7 |
GO:0060041 |
retina development in camera-type eye(GO:0060041) |
| 0.0 |
4.6 |
GO:0016568 |
chromatin modification(GO:0016568) |
| 0.0 |
0.9 |
GO:0006369 |
termination of RNA polymerase II transcription(GO:0006369) |
| 0.0 |
0.1 |
GO:0042517 |
positive regulation of tyrosine phosphorylation of Stat3 protein(GO:0042517) |
| 0.0 |
0.3 |
GO:1902591 |
vesicle coating(GO:0006901) vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) COPII-coated vesicle budding(GO:0090114) single-organism membrane budding(GO:1902591) |
| 0.0 |
0.5 |
GO:0048706 |
embryonic skeletal system development(GO:0048706) |
| 0.0 |
0.2 |
GO:0007158 |
neuron cell-cell adhesion(GO:0007158) |
| 0.0 |
0.2 |
GO:0042987 |
amyloid precursor protein catabolic process(GO:0042987) |
| 0.0 |
1.5 |
GO:0034138 |
toll-like receptor 1 signaling pathway(GO:0034130) toll-like receptor 2 signaling pathway(GO:0034134) toll-like receptor 3 signaling pathway(GO:0034138) |
| 0.0 |
0.0 |
GO:0021903 |
rostrocaudal neural tube patterning(GO:0021903) midbrain-hindbrain boundary development(GO:0030917) |
| 0.0 |
1.1 |
GO:0006977 |
DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) signal transduction involved in cell cycle checkpoint(GO:0072395) signal transduction involved in DNA integrity checkpoint(GO:0072401) signal transduction involved in mitotic cell cycle checkpoint(GO:0072413) signal transduction involved in DNA damage checkpoint(GO:0072422) signal transduction involved in mitotic G1 DNA damage checkpoint(GO:0072431) intracellular signal transduction involved in G1 DNA damage checkpoint(GO:1902400) signal transduction involved in mitotic DNA damage checkpoint(GO:1902402) signal transduction involved in mitotic DNA integrity checkpoint(GO:1902403) |
| 0.0 |
0.4 |
GO:0035338 |
long-chain fatty-acyl-CoA metabolic process(GO:0035336) long-chain fatty-acyl-CoA biosynthetic process(GO:0035338) |
| 0.0 |
0.2 |
GO:0007625 |
grooming behavior(GO:0007625) |
| 0.0 |
0.4 |
GO:0006362 |
transcription elongation from RNA polymerase I promoter(GO:0006362) |
| 0.0 |
1.4 |
GO:0008016 |
regulation of heart contraction(GO:0008016) |
| 0.0 |
0.9 |
GO:0007612 |
learning(GO:0007612) |
| 0.0 |
0.1 |
GO:0007062 |
sister chromatid cohesion(GO:0007062) |
| 0.0 |
0.6 |
GO:0006040 |
amino sugar metabolic process(GO:0006040) |
| 0.0 |
0.3 |
GO:0000725 |
double-strand break repair via homologous recombination(GO:0000724) recombinational repair(GO:0000725) |
| 0.0 |
0.2 |
GO:0042273 |
ribosomal large subunit biogenesis(GO:0042273) |
| 0.0 |
0.1 |
GO:0000239 |
pachytene(GO:0000239) |
| 0.0 |
0.1 |
GO:0002063 |
chondrocyte development(GO:0002063) |
| 0.0 |
0.4 |
GO:0071824 |
protein-DNA complex subunit organization(GO:0071824) |
| 0.0 |
0.0 |
GO:0045617 |
negative regulation of keratinocyte differentiation(GO:0045617) |
| 0.0 |
0.4 |
GO:0006413 |
translational initiation(GO:0006413) |
| 0.0 |
0.5 |
GO:0030521 |
androgen receptor signaling pathway(GO:0030521) |
| 0.0 |
0.2 |
GO:0042994 |
cytoplasmic sequestering of transcription factor(GO:0042994) |
| 0.0 |
1.4 |
GO:0006836 |
neurotransmitter transport(GO:0006836) |
| 0.0 |
0.3 |
GO:0050434 |
positive regulation of viral transcription(GO:0050434) |
